Patients The humans the algorithms can't reach Patients don’t start, stay on, or return to therapy because they receive a notification at the right time.
Sales & Marketing Breaking tradition to reimagine medical affairs workflows fo... To stay relevant, medical affairs teams must adapt how they work to meet new demands with greater agility and efficiency.
R&D Beyond good intentions: How life sciences can prove its read... While support for reducing animal use has never been stronger, the path to broad adoption is steep and complex.
R&D Big promises, hard work: What 2026 will demand from pharma Eloise McLennan looks at a set of signals areas where pressure is building and 2026 looks set to demand more clarity, discipline, and follow-through.
Digital Balancing global consistency and local nuance: EVERSANA on A... The conversation around global brand launches is evolving rapidly – and EVERSANA and its agency team at EVERSANA INTOUCH’s leadership is at the centre
Digital Harnessing AI to make Medicare more efficient, fair, and pat... As part of “WISeR” requirements, CMS selected tech vendors to implement enhanced technological models to scrutinise claims involving those on Medicare
Patients LSX2026: On promise and patience, with Hans Schambye At LSX World Congress 2026 in Lisbon, Portugal, web editor Nicole Raleigh spoke with Hans Schambye, CEO of BOOST Pharma.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
